Trxade Group (NASDAQ: MEDS), an integrated
drug-procurement, delivery and healthcare platform that enables price
transparency and increased profit margins to healthcare buyers and sellers of
pharmaceuticals, has more than 12,100 pharmacies currently registered as users
of its proprietary Supplier-to-Pharmacy (“S2P”) e-commerce platform. An article
discussing the company reads, “With the current number of users already on the
network — serving an estimated 12 to 15 million patients indirectly through
these member pharmacies, and adding about 100 new pharmacies per month —
Trxade’s goal is to reach most, if not all, of the 24,000 independent
pharmacies in the United States, which have a combined annual purchasing power
of more than $92 billion. . . . Leveraging a robust technology with optimum
buyer/seller pricing algorithms, product availability and predictive data
analytics features, the platform is designed to help independent pharmacies
identify the best available supplier prices for prescription drugs nationwide.
The platform allows its members to easily compare the price of drugs offered by
various suppliers and select the most favorable deals, saving them money by
taking advantage of best purchase pricing.”
To view the full article, visit http://ibn.fm/XbtFM
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade is an integrated
drug procurement, delivery and healthcare platform that enables price
transparency and increased profit margins to buyers and sellers of pharmaceuticals,
makes healthcare services affordable and accessible across all 50 states, and
steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is
comprised of four synergistic operating platforms: the Trxade B2B trading
platform with 12,100 registered pharmacies, a licensed virtual wholesaler,
affordable healthcare via its Bonum Health app or web-based telehealth
services, and same-day or mail-order pharmacy delivery capabilities via its
DelivMeds app featuring its extensive nationwide distribution network. For more
information, visit the company’s websites at www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates
relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to established
industry leaders, gaining valuable experience and the expertise necessary to
determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
